FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

718943005: Efmoroctocog alfa (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2017. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3314477018 Efmoroctocog alfa (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3314478011 Efmoroctocog alfa en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Efmoroctocog alfa Is a Coagulation factor VIII false Inferred relationship Existential restriction modifier
Efmoroctocog alfa Is a Fusion protein true Inferred relationship Existential restriction modifier
Efmoroctocog alfa Is a Recombinant antihemophilic factor agent false Inferred relationship Existential restriction modifier
Efmoroctocog alfa Is a Antihemophilic factor agent true Inferred relationship Existential restriction modifier
Efmoroctocog alfa Is a Recombinant coagulation factor VIII true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing efmoroctocog alfa Has active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Efmoroctocog alfa Has active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing efmoroctocog alfa in parenteral dose form (medicinal product form) Has active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing only efmoroctocog alfa in parenteral dose form (medicinal product form) Has active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 1000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 1000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 1500 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 1500 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 2000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 2000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 250 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 250 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 3000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 3000 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Product containing precisely efmoroctocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance True Efmoroctocog alfa Inferred relationship Existential restriction modifier 1
Efmoroctocog alfa 4,000unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 4,000unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 4,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 4,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 750unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 750unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 750unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 250unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 1,500unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 1,000unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 500unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 2,000unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 3,000unit powder and solvent for solution for injection vials Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 750unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 1,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 1,500unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 2,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 250unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 3,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 500unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 500unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 250unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 2,000unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 1,500unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 1,000unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Efmoroctocog alfa 3,000unit powder and solvent for solution for injection vials 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 250unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 500unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 1,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 2,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 1,500unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier
Elocta 3,000unit powder and solvent for solution for injection vials (Swedish Orphan Biovitrum Ltd) 1 vial Has specific active ingredient True Efmoroctocog alfa Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start